Skip to main content

Table 1 Characteristics of patients and endobronchial one-way valve deployment in case reports included

From: Endobronchial one-way valves for treatment of persistent air leaks: a systematic review

 

n/N

Percentage

Demographics

 Age (years), median (range)

57 (18–93)

 

 Male sex

28/51a

54.9%

 Female sex

23/51a

45.1%

Underlying diseases

 Lung infection

11/52

21.2%

 Infections of other sites

1/52

2%

 Lung related diseases

26/52

50%

 Chest trauma

1/52

2%

 Cancer

14/52

26.9%

 Systematic diseases

3/52

5.8%

Causes of air leak

 Pneumothorax

23/52

44.2%

 Tension pneumothorax

6/52

11.5%

 Iatrogenic pneumothorax

6/52

11.5%

 Broncho-cutaneous fistula

1/52

2%

 Bronchopleural fistula

6/52

11.5%

 Alveolar-pleural and trans-diaphragmatic fistula

1/52

2%

 Empyema

9/52

17.3%

 Postoperative air leak

12/52

23.1%

Duration of air leak before endobronchial one-way valve deployment (days),median (range)

15, (3–2520)

 

Location of air leak

 Right upper

17/52

32.7%

 Right middle

6/52

11.5%

 Right lower

6/52

11.5%

 Left upper

15/52

28.8%

 Left lower

8/52

15.4%

 Right main bronchus

1/52

2%

 Left main bronchus

1/52

2%

 Lingual

5/52

9.6%

 Bronchus intermedius

1/52

2%

Type of endobronchial one-way valve used

 Emphasys®

32/122

26.2%

 Spiration® IBV valves

59/122

48.4%

 Zephyr®

31/122

25.4%

Number of endobronchial one-way valves (per patient),median (range)

2, (1–8)

 

Duration of air leak after endobronchial one-way valve deployment

  < 1 day

31/50b

62%

 1 day≦ ≦2 days

6/50b

12%

  > 2 days

13/50b

26%

Outcomes

 Removal of endobronchial one-way valve

20/50c

40%

 Migration of endobronchial one-way valve

1/50c

2%

 Expectoration of endobronchial one-way valve

1/50c

2%

 Recurrence of air leak

3/50c

6%

 Death not related to deployment of endobronchial one-way valve

3/50c

6%

  1. asex of patient in one case report not given
  2. bduration of initial air leak not given in 2 case reports
  3. c1 patient lost to follow-up and 1 patient without plan to valve removal